Cargando…

Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt

AIM: The FDA approved isotretinoin for moderate and severe nodulo-cystic acne, in which it proved effective. However, this misled the dermatologists into using isotretinoin for mild cases as well. This misuse increased the risk of developing adverse effects, especially on the ocular system. These ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshafie, Mohammed, Srour, Azza, el-Ansarey, Hussien, Abdel-kader, Mostafa, Kabbash, Ibrahim, Mashaly, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457441/
https://www.ncbi.nlm.nih.gov/pubmed/34566419
http://dx.doi.org/10.2147/CCID.S327870
_version_ 1784571095478697984
author Elshafie, Mohammed
Srour, Azza
el-Ansarey, Hussien
Abdel-kader, Mostafa
Kabbash, Ibrahim
Mashaly, Mohamed
author_facet Elshafie, Mohammed
Srour, Azza
el-Ansarey, Hussien
Abdel-kader, Mostafa
Kabbash, Ibrahim
Mashaly, Mohamed
author_sort Elshafie, Mohammed
collection PubMed
description AIM: The FDA approved isotretinoin for moderate and severe nodulo-cystic acne, in which it proved effective. However, this misled the dermatologists into using isotretinoin for mild cases as well. This misuse increased the risk of developing adverse effects, especially on the ocular system. These adverse effects vary from mild reversible eye dryness to severe irreversible loss of night vision. Also, it causes contact lens intolerance and corneal ulcer on top. Both ophthalmologists and dermatologists have different perceptions of the drug. PURPOSE: To evaluate dermatologists’ knowledge and attitude toward ocular adverse effects of isotretinoin in Egypt. METHODS: This cross-sectional study was conducted via an online questionnaire. The questionnaire had three parts: 1) demographic data, 2) knowledge about isotretinoin dry eye disorders, contact lens intolerance, and refractive surgery precautions and 3) dermatologists’ management of a case on isotretinoin therapy. We contacted 111 participants from Facebook dermatologists’ groups between March and April 2021. RESULTS: We surveyed 111 dermatologists. One hundred and five (94.6%) reported their knowledge about ocular side effects. One hundred of them (90.1%) informed their patients about the drug’s adverse effects. Eighty-three (74.8%) reported their knowledge about contact lens intolerance. Forty-one dermatologists (36.9%) screened their patients for recent refractive surgery before isotretinoin therapy. Nearly, all dermatologists routinely prescribed lubricant eye drops for the patients, and 63 (56.8%) dermatologists sometimes referred their patients to an ophthalmologist. We found an association between knowledge about contact lens intolerance and years of experience (p=0.012). As well, we found that the academic degree of dermatologists is directly proportional with warning patients about ocular side effects (p=0.003) and refractive surgery (p=0.039). CONCLUSION: Egyptian dermatologists were knowledgeable about the effects of isotretinoin on eyes with inappropriate clinical practice.
format Online
Article
Text
id pubmed-8457441
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84574412021-09-23 Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt Elshafie, Mohammed Srour, Azza el-Ansarey, Hussien Abdel-kader, Mostafa Kabbash, Ibrahim Mashaly, Mohamed Clin Cosmet Investig Dermatol Original Research AIM: The FDA approved isotretinoin for moderate and severe nodulo-cystic acne, in which it proved effective. However, this misled the dermatologists into using isotretinoin for mild cases as well. This misuse increased the risk of developing adverse effects, especially on the ocular system. These adverse effects vary from mild reversible eye dryness to severe irreversible loss of night vision. Also, it causes contact lens intolerance and corneal ulcer on top. Both ophthalmologists and dermatologists have different perceptions of the drug. PURPOSE: To evaluate dermatologists’ knowledge and attitude toward ocular adverse effects of isotretinoin in Egypt. METHODS: This cross-sectional study was conducted via an online questionnaire. The questionnaire had three parts: 1) demographic data, 2) knowledge about isotretinoin dry eye disorders, contact lens intolerance, and refractive surgery precautions and 3) dermatologists’ management of a case on isotretinoin therapy. We contacted 111 participants from Facebook dermatologists’ groups between March and April 2021. RESULTS: We surveyed 111 dermatologists. One hundred and five (94.6%) reported their knowledge about ocular side effects. One hundred of them (90.1%) informed their patients about the drug’s adverse effects. Eighty-three (74.8%) reported their knowledge about contact lens intolerance. Forty-one dermatologists (36.9%) screened their patients for recent refractive surgery before isotretinoin therapy. Nearly, all dermatologists routinely prescribed lubricant eye drops for the patients, and 63 (56.8%) dermatologists sometimes referred their patients to an ophthalmologist. We found an association between knowledge about contact lens intolerance and years of experience (p=0.012). As well, we found that the academic degree of dermatologists is directly proportional with warning patients about ocular side effects (p=0.003) and refractive surgery (p=0.039). CONCLUSION: Egyptian dermatologists were knowledgeable about the effects of isotretinoin on eyes with inappropriate clinical practice. Dove 2021-09-18 /pmc/articles/PMC8457441/ /pubmed/34566419 http://dx.doi.org/10.2147/CCID.S327870 Text en © 2021 Elshafie et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Elshafie, Mohammed
Srour, Azza
el-Ansarey, Hussien
Abdel-kader, Mostafa
Kabbash, Ibrahim
Mashaly, Mohamed
Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title_full Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title_fullStr Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title_full_unstemmed Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title_short Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
title_sort dermatologists’ knowledge and attitude toward isotretinoin ocular side effects in egypt
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457441/
https://www.ncbi.nlm.nih.gov/pubmed/34566419
http://dx.doi.org/10.2147/CCID.S327870
work_keys_str_mv AT elshafiemohammed dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt
AT srourazza dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt
AT elansareyhussien dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt
AT abdelkadermostafa dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt
AT kabbashibrahim dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt
AT mashalymohamed dermatologistsknowledgeandattitudetowardisotretinoinocularsideeffectsinegypt